Sustained Activation of Fibroblast Transforming Growth Factor-β/Smad Signaling in a Murine Model of Scleroderma
- 1 July 2003
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 121 (1) , 41-50
- https://doi.org/10.1046/j.1523-1747.2003.12308.x
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Upregulation of PAI-1 is mediated through TGF-β/Smad pathway in transplant arteriopathyThe Journal of Heart and Lung Transplantation, 2002
- Transforming Growth Factor-β Repression of Matrix Metalloproteinase-1 in Dermal Fibroblasts Involves Smad3Journal of Biological Chemistry, 2001
- Smads mediate signaling of the TGFβ superfamily in normal keratinocytes but are lost during skin chemical carcinogenesisOncogene, 2001
- Modulation of Endogenous Smad Expression in Normal Skin Fibroblasts by Transforming Growth Factor-βExperimental Cell Research, 2000
- Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking SclerodermaJournal of Investigative Dermatology, 1999
- Smad-dependent Transcriptional Activation of Human Type VII Collagen Gene (COL7A1) Promoter by Transforming Growth Factor-βJournal of Biological Chemistry, 1998
- Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Increased proportion of high collagen‐producing cells in systemic sclerosis fibroblastsArthritis & Rheumatism, 1996
- Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: Insensitivity to TGFβ1 stimulationBiochemical and Biophysical Research Communications, 1992
- Transcription and Expression of Transforming Growth Factor Type Beta in the Skin of Progressive Systemic Sclerosis: A Mediator of Fibrosis?Journal of Investigative Dermatology, 1990
- Elevated proα2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding geneFEBS Letters, 1987